Recent Development of Organic Afterglow Probes for Diagnosis and Treatment of Cancer DOI Open Access

Meiqin Li,

Le Tu, Huiling Wang

et al.

Targets, Journal Year: 2024, Volume and Issue: 2(4), P. 327 - 340

Published: Oct. 31, 2024

Afterglow imaging plays a crucial role in the cancer treatment field. In contrast to inorganic afterglow agents, organic agents possess easily modifiable structures and exhibit excellent biocompatibility, thereby presenting significant prospects for application tumor diagnosis management. this review, we summarize design principles applications of probes therapy. Finally, discuss future challenges

Language: Английский

Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer DOI Creative Commons
Lin Zhao, Haipeng Cheng, Zhongyi Tong

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: Aug. 22, 2024

Pyroptosis, a lytic form of cell death mediated by the gasdermin family, is characterized swelling and membrane rupture. Inducing pyroptosis in cancer cells can enhance antitumor immune responses promising strategy for therapy. However, excessive may trigger development inflammatory diseases due to immoderate continuous reactions. Nanomaterials nanobiotechnology, renowned their unique advantages diverse structures, have garnered increasing attention owing potential induce such as cancer. A nano-delivery system drug-induced overcome limitations small molecules. Furthermore, nanomedicines directly manipulate pyroptosis. This review summarizes discusses latest advancements nanoparticle-based treatments with among cancer, focusing on functions mechanisms providing valuable insights into selecting nanodrugs clinical application these strategies still faces challenges limited understanding nanobiological interactions. Finally, future perspectives emerging field pyroptotic nanomaterials are presented.

Language: Английский

Citations

7

MOF-Derived Oxygen-Deficient Titania-Mediated Photodynamic/Photothermal-Enhanced Immunotherapy for Tumor Treatment DOI
Xin Jiang, Zhengjie Huang, Zhuqing Liu

et al.

ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(27), P. 34591 - 34606

Published: June 25, 2024

Immunotherapy has emerged as a revolutionizing therapeutic modality for cancer. However, its efficacy been largely limited by weak immune response and an immunosuppressive tumor microenvironment. Herein, we report metal–organic framework (MOF)-derived titanium oxide nanoparticle (MCTx NP) booster that can greatly improve the immunotherapy inducing "immunogenic cell death" (ICD) remodeling The NPs, inheriting characteristic structure of MIL-125 enriched with oxygen vacancies (OVs), demonstrate both high photothermal conversion efficiency reactive species (ROS) generation yield upon near-infrared (NIR) activation. Moreover, NPs release O2 reduce glutathione (GSH) in environment, showcasing their potential to reverse In vitro/vivo results MCTx directly kill cells effectively eliminate primary tumors exerting dual photodynamic/photothermal therapy under single NIR irritation. At same time, augment PD-L1 blockade potently ICDs reversing microenvironment, including promoting dendritic (DC) maturation, decreasing regulatory T (Tregs)' infiltration, increasing cytotoxic lymphocytes (CTLs) helper (Ths), resulting effective distant suppression. This work highlights NP-mediated photodynamic- photothermal-enhanced strategy treatment.

Language: Английский

Citations

4

An Ultrasound‐Activated Supramolecular Modulator Enhancing Autophagy to Prevent Ventricular Arrythmias Post‐Myocardial Infarction DOI

Yida Pang,

Qian Li, Jiale Wang

et al.

Angewandte Chemie International Edition, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 18, 2024

Ventricular arrhythmias (VAs) triggered by myocardial infarction (MI) are the leading cause of sudden cardiac mortality worldwide. Current therapeutic strategies for managing MI-induced VAs, such as left stellate ganglion resection and ablation, suboptimal, highlighting need to explore safer more effective intervention strategies. Herein, we rationally designed two supramolecular sonosensitizers RuA RuB, engineered through acceptor modification generate moderate reactive oxygen species (ROS) modulate VAs. Both RuB demonstrated high ultrasound (US)-activated ROS production efficiency, with singlet (

Language: Английский

Citations

3

Targeted Covalent Nanodrugs Reinvigorate Antitumor Immunity and Kill Tumors via Improving Intratumoral Accumulation and Retention of Doxorubicin DOI
Zhijia Zhu,

Yanxue Shang,

Chi-Kuan Lin

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 6, 2025

Specifically improving the intratumoral accumulation and retention achieving maximum therapeutic efficacy of small-molecule chemotherapeutics remains a considerable challenge. To address issue, we here reported near-infrared (NIR) irradiation-activatable targeted covalent nanodrugs by installing diazirine-labeled transferrin receptor 1 (TfR1)-targeted aptamers on PEGylated phospholipid-coated upconversion nanoparticles followed doxorubicin loading. Targeted recognized then were activated to covalently cross-link with TfR1 cancer cells 980 nm NIR irradiation. Systematic studies revealed that they achieved >6- >5.5-fold higher accumulations than aptamer-based at 6 120 h post intravenous injection, respectively. Based high drug delivery efficacy, boosted doxorubicin-induced immunogenic cell death, antitumor immune responses shrank sizes both primary distant tumors, displayed better less adverse effect commercial Doxil in 4T1 syngeneic breast tumor model featuring an immunosuppressive microenvironment. By integrating specificity molecular recognition, reactivity profile diazirine accuracy light manipulation nanodrug supremacy, our could be expected as longer-term efficient strategy improve anticancer chemotherapeutics.

Language: Английский

Citations

0

Metal-based immunogenic cell death inducers for cancer immunotherapy DOI Creative Commons
Jun Zou, Meng Rui Chang, Nikita A. Kuznetsov

et al.

Chemical Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Immunogenic cell death (ICD) has attracted enormous attention over the past decade due to its unique characteristics in cancer and role activating innate adaptive immune responses against tumours. Many efforts have been dedicated screening, identifying discovering ICD inducers, resulting validation of several based on metal complexes. In this review, we provide a comprehensive summary current metal-based their molecular mechanisms for triggering initiation subsequent protective antitumour responses, along with considerations validating both vitro vivo. We also aim offer insights into future development complexes enhanced ICD-inducing properties applications potentiating immunity.

Language: Английский

Citations

0

Anthracene and pyrene containing fluorescent metallacycles/cages (MOCs) and their applications DOI Creative Commons

Jiaxing Du,

Meng Yu, Wei Tuo

et al.

APL Materials, Journal Year: 2025, Volume and Issue: 13(5)

Published: May 1, 2025

Metal–organic cycle/cages (MOCs) are a class of molecular structures characterized by their unique shapes and dimensions, created using the systematic combination an organic donor metal center. Due to versatile properties, MOCs highly useful in materials science. Owing structural photoelectric polycyclic aromatic hydrocarbons have significant application potential optoelectronic devices, chemical sensing, biomedical fields. Fluorescent constructed with units such as anthracene pyrene backbones show fluorescence properties broad applications recognition, bioimaging, functional materials. This review highlights latest research progress on these multiple areas, including luminescence, resonance energy transfer, host–guest chemistry, bioimaging. In addition, design strategies related involving conformational distortions cycloaddition reactions discussed. provides summary advances this field during past three years.

Language: Английский

Citations

0

Breaking Barriers in Oncology: Harnessing Sonodynamic Therapy for Enhanced Tumor Metabolism Regulation DOI
Yangmengfan Chen, Kun Li, Hao Du

et al.

Small, Journal Year: 2025, Volume and Issue: unknown

Published: May 2, 2025

Abstract The recent booming development of sonometabolism regulation in controlling the tumor microenvironment (TME) has opened a new research area to identify innovative approaches against cancer. aim this review is highlight potentials and advantages sonodynamic therapy (SDT) antitumor nanotherapies, specifically, delineating progress made SDT concerning TME metabolism which encompasses factors such as hypoxia, redox balance, autophagy, immunosuppression, ion homeostasis, other metabolic processes. By focusing on both cell dynamics, wide range strategies that have demonstrated great therapeutic effectiveness by targeting functions inherent are summarized. In conclusion, offers valuable insights for researchers involved SDT‐based strategies, with advancing methodologies future research.

Language: Английский

Citations

0

Simply Designed and Universal DNA Nanohydrogel for Stimuli-Responsive NIR-II Fluorescence Imaging of Early-Stage Tumor DOI Creative Commons
Feng Gao,

Lichao Guo,

Wanjuan Lin

et al.

Analytical Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: May 13, 2025

The delayed detection and recurrence of cancer lead to disappointing cure rates, underscoring the imperative for exploring precise early tumor diagnosis techniques. Despite superior biocompatibility flexible programmability DNA nanoprobes imaging, intricate designs with multiple oligonucleotide sequences are always indispensable, which significantly hinder their clinical application commercial development. To construct a simply designed nanoprobe, here, we constructed universal stimuli-responsive nanohydrogel through hybridization staple strand skeleton strand. Through simple substitution strand, this hydrogel can be adapted response different targets without necessitating series subsequent revisions synthesis optimization. achieve near-infrared II region (NIR-II) fluorescence alkynyl-modified NIR-II fluorescent dyes labeled at two ends bent strands display weak because aggregation-caused quenching effect. highly expressed ATP or cytokine in cells activates liberation staples collapse configuration, generates recovery imaging. Moreover, also allows targeted release anticancer drugs intercalated helix. By integration dyes, versatile enables treatment tumors. straightforward design demonstrates low cost easy adaptability multitarget detection, highlighting its significant implications advancement nanotechnology commercialization production.

Language: Английский

Citations

0

De Novo Design of Efficient NIR‐II‐Activated Heavy‐Atom‐Free Type‐I Photosensitizer for Anti‐Tumor Photoimmunotherapy DOI
Huan Chen, Yu Wang,

Zhangxin He

et al.

Advanced Materials, Journal Year: 2025, Volume and Issue: unknown

Published: June 4, 2025

Abstract Type‐I photosensitizers (PSs) are considered to be efficient agents for overcoming the oxygen‐dependent deficiency of traditional photodynamic therapy (PDT). However, it is still challenging design type‐I PSs that can activated by second near‐infrared (NIR‐II) irradiation. Herein, a series organic heavy‐atom‐free molecules designed (named as CTU1 , CTU2 and CTU3 ) exhibit strong absorption bands over first NIR‐II regions. Among them, water‐dispersible nanoparticles (NPs) show J ‐aggregate characteristics good band, resulting in highly •O 2 − generation upon irradiation 1064 nm light. In addition, NPs also high photothermal conversion efficiency 88.6%. vitro vivo experiments have superior PDT (PTT) effects, which further induce immunogenic cell death activate immune cells 4T1 tumor‐bearing mice combined PDT/PTT anti‐tumor photoimmunotherapy against refractory tumors. This work presents paradigm de novo light‐activated PS combinational cancer.

Language: Английский

Citations

0

Dual‐Defect Nitrogen‐Rich Carbon Nitride‐Based Heterostructural Nanocatalyst for Improving the Therapeutic Efficacy of αPD‐1 via Tumor Immune Microenvironment Remodelling DOI
Tingting Hu, Chuan Hu,

Yinwen Ji

et al.

Advanced Materials, Journal Year: 2025, Volume and Issue: unknown

Published: June 4, 2025

Abstract Low immunogenicity, insufficient immune infiltrates, and inhibitive microenvironment of tumors ruthlessly weakened the therapeutic efficacy immunotherapies. How to improve therapy by reshaping tumor still remains a challenge that needs be urgently addressed. Here, novel dual‐defect nitrogen‐rich carbon nitride‐based heterostructural nanocatalyst (CNO@CuMS) possessing brilliant piezocatalytic H 2 O generation, sonocatalytic 1 Fenton‐like catalytic •OH cell cuproptosis inducing properties are developed. Accompanied ultrasonic treatment, immunogenic death (ICD) subsequent releasing damage‐associated molecular patterns (DAMPs) cells successfully triggered CNO@CuMS, which resulted in activation systematic antitumor response enhanced infiltration CD8 + cytotoxic T lymphocytes natural killer (NK) at site. The large quantitatively generated reactive oxygen species (ROS) also promoted polarization M2‐type macrophage M1‐type as well. Benefitting from this remodelling effect, remarkable malignant orthotopic osteosarcoma is achieved employing CNO@CuMS α PD‐1 combination strategy under with no significant side effects observed. This research not only proposes method fabricate high proformance but provides new realize highly efficient bone during clinical practice.

Language: Английский

Citations

0